Huge numbers of people have experienced CFS/ME, and continue to do so

The argument

One argument that chronic fatigue syndrome (CFS/ME) is a real illness rests on its sheer scale: it affects an enormous number of people across the world, far too many to be dismissed as imagined or anomalous. Estimates put the number of sufferers in the millions globally, with hundreds of thousands in countries such as the United Kingdom and the United States alone. Health bodies including the World Health Organization classify the condition, and it is recognised by national health services and medical institutions as a genuine diagnosis. A condition reported by so many people, across different countries, cultures and health systems, has a consistency and prevalence that points to a real underlying disease rather than a fluke or a fashion. The argument draws weight from the similarity of what sufferers describe. Independently of one another, people with CFS/ME report the same distinctive cluster of symptoms — profound, persistent exhaustion unrelieved by rest, post-exertional malaise in which symptoms worsen after activity, cognitive difficulties, unrefreshing sleep and pain. That a recognisable and consistent syndrome appears again and again in unconnected individuals is itself evidence of a real pathological entity; coincidence or suggestion would not produce so uniform a picture across so many separate lives. The lived reality of these millions, proponents argue, cannot simply be waved away. When an illness is experienced in the same way by vast numbers of people who have never met, and is acknowledged by the institutions of medicine, the most reasonable conclusion is that it is real. Because huge numbers of people have experienced CFS/ME, with the same consistent symptoms, this argument holds, it is a real illness.

Premises

Counter-arguments

Those who question the argument's reasoning note that prevalence and reported consistency do not, on their own, establish a discrete biological disease. Many people sharing similar symptoms can reflect a common final pathway of very different underlying causes, or the way a diagnostic label groups heterogeneous conditions together, rather than one entity — and official classification records that a syndrome is recognised for clinical purposes without settling its mechanism. Historically, sceptics (the sibling position) seized on the long absence of a definitive biomarker to argue the diagnosis was ill-defined. The stronger case for the illness's reality, defenders themselves now stress, rests on emerging biomedical findings — immune, metabolic and post-viral abnormalities — rather than on numbers and symptom-reports alone, which is the narrower ground this particular argument stands on.

Rejecting the premises

[Rejecting P1] Large numbers of people reporting similar symptoms can reflect a shared final pathway of different underlying causes, or a broad diagnostic label, rather than proving a single discrete disease. [Rejecting P2] Institutional recognition and classification track that a syndrome is treated as a clinical entity, not that its biological mechanism is established, so recognition does not by itself settle the question the argument answers.